- Save article
NewsBayer Pensionskasse invests €950m in fixed income
The scheme pushed for investments in interest-bearing registered securities to keep the weight of the asset class stable in the long term
- Save article
NewsBayer on track to adjusting pension plans for employees
The company plans to decouple the basic pension provided by the Rheinische Pensionskasse and the direct promise (Direktzusage) arrangement
- Save article
NewsBayer Pensionskasse CEO calls for minimum standards for IORP liquidity risks
Stephan Nellshen said a ‘one-size-fits-all’ approach to dealing with liquidity risks, especially at the European level, would not work well
- Save article
NewsSwiss Bayer Pensionskasse realigns investment strategy
Allocations to bonds increase, while exposure to mortgages and real estate decrease
- Save article
NewsBayer Group Pension Plan in £280m buy-in with Canada Life
The transaction secures the benefits of 40% of the plan’s pensioners, with umbrella contract allowing to insure further liabilities in the future.
- Save article
NewsBayer Pensionskasse prioritises fixed income high credit rating allocation
Following an ALM study last autumn, the scheme has adjusted its strategic asset allocation
- Save article
NewsGerman court ruling gives green light to investors’ lawsuit against Bayer
Investors including reinsurance companies and pension funds from Germany, other EU member states, North America, Asia and Australia, have sued Bayer for damages
- Save article
NewsGerman corporate pension funds tilt towards fixed income amid risk concerns
While continuing to increase their allocations to private markets, drawn by the potential for improved risk-adjusted returns and greater diversification
- Save article

White papersBuilding the future of innovation: Selecting cities for life sciences real estate in Europe
In the rapidly advancing realm of biotechnology and pharmaceuticals, life sciences real estate is more than bricks and mortar – it’s the enabler of innovation. Investors venturing into this specialized asset class are essentially betting on ecosystems that need real estate to grow. Think of it as the skeleton that keeps the muscles in place and the body as a whole standing. There are certain strategic parameters that can be used to select the right European cities for life sciences real estate investments. This must then be woven in with external push and pull factors that are forcing companies in the life sciences sector to adjust when it comes to their real estate footprint.
- Save article
NewsPeople moves: AllianzGI picks new leads for private and public teams
Edouard Jozan has been appointed as head of AllianzGI private markets
- Save article
AnalysisGerman companies rethink occupational pension plans
German corporates reorganise their pension plans in a bid to win over talent, fight skilled workers shortage, and exploit opportunities for a flexible transition to retirement
- Save articleNews
EIOPA stress tests to give German IORPs 'headaches', Bayer warns
CFO warns of disincentives for long-term investments due to stress tests, QA exercises
- Save article
NewsPension funds should not be treated as NBFIs, PensionsEurope tells EC
Industry association responds to consultation that will inform policy planning in the Commission’s new political mandate
- Save article
NewsGerman pensions industry pins hope on next cabinet for second pillar reform
Germany’s occupational pension industry has been let down by the sudden halt of the second pillar pension system reform process, triggered by a political crisis, as it pins its hope on the next government to build on the groundwork laid out so far. Speaking at the Handelsblatt occupational forum in ...
- Save article
NewsBigger Irish presence as EIOPA names OPSG members for new term
New faces also include Dijana Bojceta Markoja, from the Association of Pension Funds and Insurance Companies in Croatia
- Save article
NewsPRI’s Spring initiative calls for investor engagement on nature policy influence
The initiative targets 40 focus companies across the food and agriculture, mineral mining, automotive, chemicals and banking sectors
- Save article
FeaturesHow seven European pension funds view active management
IPE asked leading European pension funds for their views on active management, with turmoil in the equity markets and continuing geopolitical uncertainty around the world
White papersBuilding the future of innovation
Selecting cities for life sciences real estate in Europe
White papersUncovering the qualities that set compounders apart
Compounder companies (“compounders”) are those with highly visible and long-duration growth. Lindy’s Law explains an anti-ageing process for such companies — the longer they exist, the stronger they become to survive well into the future. This enables many to become industry leaders and dominant global players. We refer to these types of venerable companies as “marathon runners”. They form the bedrock of the returns we generate for our clients. It’s not just their age that sets these companies apart. It’s the combination of unique corporate culture and resilience that keeps them growing in good and bad times.





